Medifast Inc
MED· NYSE
MEDMedifast Inc
Filed Feb 23, 2022 · 10-K · 54 days after period end · 0001628280-22-003534
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020 | Q4 2019 | Q4 2018 |
|---|---|---|---|---|
| Revenue | $377.83M | $264.91M | $170.63M | $145.84M |
| Net Income | $34.02M | $27.99M | $19.88M | $15.65M |
| EPS Diluted | — | $2.36 | $1.66 | $1.30 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Feb 23, 2022 · 54 d after period end
